Accelerating new treatments for neurological disease.

We enable the next generation of therapeutic devices, clinical services, and disease-modifying therapeutic drugs for patients with neurological disease.

Learn more about what we do

Better therapeutics through data.

One billion people worldwide are affected by neurological diseases like Epilepsy, Parkinson’s disease, Alzheimer’s disease, psychiatric illness, traumatic brain injury, ALS and other neurodegenerative diseases, for which there are no disease-modifying treatments. There is a massive opportunity to impact health globally by developing effective treatments and care for these patients. We're using our data integration and analysis platform to tackle this need.

Closed-loop control for personalized therapy.

Enabling real-time, closed-loop control of implanted devices for personalized therapy.

Therapeutic Devices →

Improved outcomes for patients at lower cost.

Analyzing real-time, integrated patient data to improve clinical outcomes and lower cost.

Clinical Services →

Treat the disease, not the symptoms.

Facilitating the discovery of multimodal biomarkers and new targets for drug development.

Therapeutic Drugs →

Our Platform

Discover novel patterns in your data.

Explore, visualize and analyze data in context. The Blackfynn platform allows users to focus on extracting meaningful information from complex multimodal scientific and clinical data — all in an intutive, cloud-based platform.

Learn more about our platform
Screenshot of our platform
icon-clinical-services Dribbble Close menu icon-devices GitHub Twitter Menu icon-medicine LinkedIn icon Monogram Google blackfynn_logo_mark_RGB_FULL